Modafinil for excessive daytime sleepiness in myotonic dystrophy type 1 - The patients' perspective

Neuromuscular Disorders

Volumn 22, Issue 7, 2012, Pages 597-603

  Hilton Jones, D ^a   Bowler, M ^b   Lochmueller, H ^c   Longman, C ^d   Petty, R ^e   Roberts, M ^f   Rogers, M ^g   Turner, C ^h   Wilcox, D ^d  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b Myotonic Dystrophy Support Group   (United Kingdom)

^c INSTITUTE OF HUMAN GENETICS   (United Kingdom)

^d ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^e SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^f HOPE HOSPITAL   (United Kingdom)

^g UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^h NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Epworth sleepiness scale; Excessive daytime sleepiness; Maintenance of wakefulness test; Modafinil; Multiple sleep latency test; Myotonic dystrophy

Indexed keywords

MODAFINIL;

AGGRESSION; ANXIETY; ARTICLE; CAREGIVER; DAYTIME SOMNOLENCE; DECREASED APPETITE; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; DIZZINESS; DRUG DEPENDENCE; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG SAFETY; EXCESSIVE DAYTIME SLEEPINESS; GASTROESOPHAGEAL REFLUX; HALLUCINATION; HEART ARRHYTHMIA; HEART FAILURE; HEART PALPITATION; HUMAN; INSOMNIA; IRRITABILITY; MAJOR CLINICAL STUDY; MOUTH ULCER; MYOTONIC DYSTROPHY; NAUSEA; NECK PAIN; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SIDE EFFECT; SKIN MANIFESTATION; SKIN TOXICITY; THORAX PAIN; TREATMENT RESPONSE; WEIGHT REDUCTION; XEROSTOMIA;

BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; DISORDERS OF EXCESSIVE SOMNOLENCE; FEMALE; GREAT BRITAIN; HUMANS; MALE; MYOTONIC DYSTROPHY; QUESTIONNAIRES;

EID: 84862180232     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2012.02.005     Document Type: Article

References (21)

1. Hilton-Jones D. Myotonic dystrophy-forgotten aspects of an often neglected condition. Curr Opin Neurol 1997, 10:399-401.
2. Turner C., Hilton-Jones D. The myotonic dystrophies: diagnosis and management. J Neurol Neurosurg Psychiatry 2010, 81:358-367.
3. Lavault S., Dauvilliers Y., Drouot X., et al. Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy. Sleep Med 2011, 12:550-556.
4. Keating G.M., Raffin M.J. Modafinil: a review of its use in excessive sleepiness associated with obstructive sleep apnoea/hypopnoea syndrome and shift work sleep disorder. CNS Drugs 2005, 19:785-803.
5. Damian M.S., Gerlach A., Schmidt F., Lehmann E., Reichmann H. Modafinil for excessive daytime sleepiness in myotonic dystrophy. Neurology 2001, 56:794-796.
6. MacDonald J.R., Hill J.D., Tarnopolsky M.A. Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy. Neurology 2002, 59:1876-1880.
7. Talbot K., Stradling J., Crosby J., Hilton-Jones D. Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy. Neuromuscul Disord 2003, 13:357-364.
8. Orlikowski D., Chevret S., Quera-Salva M.A., et al. Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial. Clin Ther 2009, 31:1765-1773.
9. Wintzen A.R., Lammers G.J., Van Dijk J.G. Does modafinil enhance activity of patients with myotonic dystrophy? A double-blind placebo-controlled crossover study. J Neurol 2007, 254:26-28.
10. Annane D, Moore DH, Barnes PR, Miller RG. Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy. Cochrane Database Syst Rev 2006;3:CD003218.
11. Laberge L., Dauvilliers Y., Begin P., Richer L., Jean S., Mathieu J. Fatigue and daytime sleepiness in patients with myotonic dystrophy type 1: to lump or split?. Neuromuscul Disord 2009, 19:397-402.
12. Laberge L., Gagnon C., Jean S., Mathieu J. Fatigue and daytime sleepiness rating scales in myotonic dystrophy: a study of reliability. J Neurol Neurosurg Psychiatry 2005, 76:1403-1405.
13. Hilton Jones D, Damian MS, Meola G. Somnolence and its management. In: Harper P, et al. editor. Myotonic dystrophy; present management, future therapy. Oxford: Oxford University Press; 2004. p. 135-149.
14. Romigi A., Izzi F., Pisani V., et al. Sleep disorders in adult-onset myotonic dystrophy type 1: a controlled polysomnographic study. Eur J Neurol 2011, 18:1139-1145.
15. Boentert M., Young P. Fatigue, excessive daytime sleepiness, and sleep-related breathing disorders in patients with myotonic dystrophies. Somnologie 2011, 15:47-52.
16. Yu H., Laberge L., Jaussent I., et al. Daytime sleepiness and REM sleep characteristics in myotonic dystrophy: a case-control study. Sleep 2011, 34:165-170.
17. Kumar S.P., Sword D., Petty R.K.H., Banham S.W., Patel K.R. Assessment of sleep studies in myotonic dystrophy. Chron Respir Dis 2007, 4:15-18.
18. Guilleminault C., Philip P., Robinson A. Sleep and neuromuscular disease: bilevel positive airway pressure by nasal mask as a treatment for sleep disordered breathing in patients with neuromuscular disease. J Neurol Neurosurg Psychiatry 1998, 65:225-232.
19. Kiyan E., Okumus G., Cuhadaroglu C., Deymeer F. Sleep apnea in adult myotonic dystrophy patients who have no excessive daytime sleepiness. Sleep Breath 2010, 14:19-24.
20. van der Meche F.G., Boogaard J.M., van den Berg B. Treatment of hypersomnolence in myotonic dystrophy with a CNS stimulant. Muscle Nerve 1986, 9:341-344.
21. Laberge L., Begin P., Montplaisir J., Mathieu J. Sleep complaints in patients with myotonic dystrophy. J Sleep Res 2004, 13:95-100.